ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Background
COVID-19 severity varies widely. Although some demographic and cardio-metabolic factors, including age and obesity, are associated with increasing risk of severe illness, the underlying mechanism(s) are uncertain.
Subjects/methods
In a meta-analysis of three independent studies of 1471 participants in total, we investigated phenotypic and genetic factors associated with subcutaneous adipose tissue expression of Angiotensin I Converting Enzyme 2 ( ACE2 ), measured by RNA-Seq, which acts as a receptor for SARS-CoV-2 cellular entry.
Results
Lower adipose tissue ACE2 expression was associated with multiple adverse cardio-metabolic health indices, including type 2 diabetes (T2D) ( P = 9.14 × 10 −6 ), obesity status ( P = 4.81 × 10 −5 ), higher serum fasting insulin ( P = 5.32 × 10 −4 ), BMI ( P = 3.94 × 10 −4 ), and lower serum HDL levels ( P = 1.92 × 10 −7 ). ACE2 expression was also associated with estimated proportions of cell types in adipose tissue: lower expression was associated with a lower proportion of microvascular endothelial cells ( P = 4.25 × 10 −4 ) and higher proportion of macrophages ( P = 2.74 × 10 −5 ). Despite an estimated heritability of 32%, we did not identify any proximal or distal expression quantitative trait loci (eQTLs) associated with adipose tissue ACE2 expression.
Conclusions
Our results demonstrate that individuals with cardio-metabolic features known to increase risk of severe COVID-19 have lower background ACE2 levels in this highly relevant tissue. Reduced adipose tissue ACE2 expression may contribute to the pathophysiology of cardio-metabolic diseases, as well as the associated increased risk of severe COVID-19.
Article activity feed
-
-
SciScore for 10.1101/2020.08.11.20171108: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable In the FUSION study, which included both males and females, analyses were also performed in males and females separately, excluding the sex covariate in the models. Table 2: Resources
Software and Algorithms Sentences Resources Blood/cell-type proportions for each FUSION adipose sample were estimated using the unmix function from DESeq2 v1.18.155. DESeq2suggested: (DESeq, RRID:SCR_000154)METSIM RNASeq data have been deposited in the Gene Expression Omnibus (GEO) under accession GSE135134. Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, …SciScore for 10.1101/2020.08.11.20171108: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable In the FUSION study, which included both males and females, analyses were also performed in males and females separately, excluding the sex covariate in the models. Table 2: Resources
Software and Algorithms Sentences Resources Blood/cell-type proportions for each FUSION adipose sample were estimated using the unmix function from DESeq2 v1.18.155. DESeq2suggested: (DESeq, RRID:SCR_000154)METSIM RNASeq data have been deposited in the Gene Expression Omnibus (GEO) under accession GSE135134. Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, RRID:SCR_005012)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-